Cytiva is a privately owned company headquartered in the US. Founded in 1968, the company provides life sciences brands such as ÄKTA, Amersham, HyClone, MabSelect, and Whatman.
On April 2, 2026, Cytiva showcased its Protein Select™ resin, with Athebio AG's Senior Research Associate Simon Flückiger sharing insights in a webinar on how the technology streamlines tag-free protein purification, cutting process time and addressing traditional workflow challenges. The same day, at Cytiva’s Burnaby site, senior electrical engineer Leanna focused on upstream concept development, refining new ideas for workcells with an emphasis on reliability and usability. Previously, on April 1, Yoshindo announced its plan to begin manufacturing biosimilar APIs at its Toyama Prefecture plant as early as 2028, supported by Cytiva to enhance its in-house production capabilities. Earlier, on March 31, Cytiva’s Burnaby site highlighted the role of quality control specialist Andrew in ensuring the precise construction of components for SA25 and Microcell™ workcells, underscoring quality in aseptic filling.
Subscribe for full access to Cytiva's products in full detail
Subscribe for full access to Cytiva's revenue in full detail
Subscribe for full access to Cytiva's products in full detail 
